NFKB1 and non-small cell lung carcinoma: To further evaluate whether NF-κB signaling pathway is responsible for NSCLC cell migration and invasion regulated by Id-1, we performed rescue experiments by treatment with NF-κB activator TNF-α and NF-κB translocation inhibitor JSH-23.